Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 281
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00691002 | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds | ||
| NCT00263718 | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris | ||
| NCT01963793 | Topical Aprepitant in Prurigo Patients | ||
| NCT01007591 | A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas | ||
| NCT00704262 | Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds | ||
| NCT04301362 | Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | ||
| NCT00135863 | MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis | ||
| NCT03325296 | Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata. | ||
| NCT02600598 | Biological Effects of LEO 43204 in Actinic Keratosis | ||
| NCT02421471 | PMS to Evaluate the Safety and Efficacy of Picato® Gel | ||
| NCT01347255 | A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris | ||
| NCT01211964 | LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects | ||
| NCT05958407 | A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy | ||
| NCT02695940 | Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis | ||
| NCT02716714 | Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis | ||
| NCT01707043 | Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris | ||
| NCT02636101 | Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study | ||
| NCT01130025 | Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer | ||
| NCT00417937 | A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily | ||
| NCT00617903 | Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea | ||
| NCT00986856 | Fucidin® Cream in the Treatment of Impetigo | ||
| NCT02580773 | Therapeutic Anticoagulation Strategy for Acute Chest Syndrome | ||
| NCT02305888 | Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively | ||
| NCT03514511 | Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis | ||
| NCT00833872 | LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects | ||
| NCT07487948 | Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris | ||
| NCT02424305 | Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions | ||
| NCT05332366 | A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia | ||
| NCT07603193 | Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream | ||
| NCT02547233 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up | ||
| NCT05923099 | A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis | ||
| NCT01892137 | Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05% | ||
| NCT02549339 | Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up | ||
| NCT01587755 | Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) | ||
| NCT03549416 | BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis | ||
| NCT00626795 | Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL) | ||
| NCT02899962 | LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris | ||
| NCT00640822 | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds | ||
| NCT00186745 | Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure | ||
| NCT01043224 | A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris | ||
| NCT01293383 | A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects | ||
| NCT00404196 | LEO19123 Cream in the Treatment of Hand Eczema | ||
| NCT03054727 | Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) | ||
| NCT01293357 | A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects | ||
| NCT03587805 | Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND | ||
| NCT01930396 | Use of Tinzaparin for Anticoagulation in Hemodialysis | ||
| NCT03476746 | Dermatopharmacokinetic Trial of LEO 90100 Foam | ||
| NCT00506519 | Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis | ||
| NCT02881346 | Efficacy and Tolerability of Enstilar® in Daily Practice | ||
| NCT02856542 | Real-life Evaluation of the Daivobet® Gel Applicator |
